Annual CFI
$3.65 M
-$8.74 M-70.55%
31 March 2022
Summary:
Sio Gene Therapies annual cash flow from investing activities is currently $3.65 million, with the most recent change of -$8.74 million (-70.55%) on 31 March 2022. During the last 3 years, it has fallen by -$8.74 million (-70.55%).SIOX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
-$177.00 K-100.00%
31 December 2022
Summary:
Sio Gene Therapies quarterly cash flow from investing activities is currently $0.00, with the most recent change of -$177.00 thousand (-100.00%) on 31 December 2022.SIOX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$459.00 K
+$142.00 K+23.63%
31 December 2022
Summary:
Sio Gene Therapies TTM cash flow from investing activities is currently -$459.00 thousand, with the most recent change of +$142.00 thousand (+23.63%) on 31 December 2022.SIOX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -70.5% | +100.0% | -102.8% |
| 5 y5 years | +1905.9% | +100.0% | -21.4% |
SIOX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -70.5% | -100.0% | -102.8% |
Sio Gene Therapies Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | $0.00(-100.0%) | -$459.00 K(-23.6%) |
| Sept 2022 | - | $177.00 K(-163.9%) | -$601.00 K(-24.1%) |
| June 2022 | - | -$277.00 K(-22.8%) | -$792.00 K(-121.7%) |
| Mar 2022 | $3.65 M(-70.5%) | -$359.00 K(+152.8%) | $3.65 M(-78.1%) |
| Dec 2021 | - | -$142.00 K(+914.3%) | $16.64 M(-0.2%) |
| Sept 2021 | - | -$14.00 K(-100.3%) | $16.66 M(+0.6%) |
| June 2021 | - | $4.16 M(-67.0%) | $16.57 M(+33.8%) |
| Mar 2021 | $12.39 M(-4957.3%) | $12.63 M(<-9900.0%) | $12.39 M(-5015.1%) |
| Dec 2020 | - | -$117.00 K(+5.4%) | -$252.00 K(+19.4%) |
| Sept 2020 | - | -$111.00 K(+484.2%) | -$211.00 K(+7.7%) |
| June 2020 | - | -$19.00 K(+280.0%) | -$196.00 K(-23.1%) |
| Mar 2020 | -$255.00 K(+26.2%) | -$5000.00(-93.4%) | -$255.00 K(-32.5%) |
| Dec 2019 | - | -$76.00 K(-20.8%) | -$378.00 K(+5.6%) |
| Sept 2019 | - | -$96.00 K(+23.1%) | -$358.00 K(+27.9%) |
| June 2019 | - | -$78.00 K(-39.1%) | -$280.00 K(+38.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | -$202.00 K(-95.3%) | -$128.00 K(+128.6%) | -$202.00 K(+80.4%) |
| Dec 2018 | - | -$56.00 K(+211.1%) | -$112.00 K(-83.0%) |
| Sept 2018 | - | -$18.00 K(<-9900.0%) | -$659.00 K(-68.8%) |
| June 2018 | - | $0.00(-100.0%) | -$2.11 M(-50.7%) |
| Mar 2018 | -$4.28 M(+3980.0%) | -$38.00 K(-93.7%) | -$4.28 M(+0.9%) |
| Dec 2017 | - | -$603.00 K(-59.0%) | -$4.25 M(+14.4%) |
| Sept 2017 | - | -$1.47 M(-32.2%) | -$3.71 M(+65.1%) |
| June 2017 | - | -$2.17 M(<-9900.0%) | -$2.25 M(+2041.0%) |
| Mar 2017 | -$105.00 K(-98.0%) | $0.00(-100.0%) | -$105.00 K(-83.5%) |
| Dec 2016 | - | -$69.00 K(+762.5%) | -$636.00 K(-88.1%) |
| Sept 2016 | - | -$8000.00(-71.4%) | -$5.34 M(-0.4%) |
| June 2016 | - | -$28.00 K(-94.7%) | -$5.37 M(+0.4%) |
| Mar 2016 | -$5.35 M | -$531.00 K(-88.9%) | -$5.35 M(+11.0%) |
| Dec 2015 | - | -$4.78 M(>+9900.0%) | -$4.82 M(>+9900.0%) |
| Sept 2015 | - | -$30.00 K(+328.6%) | -$37.00 K(+428.6%) |
| June 2015 | - | -$7000.00 | -$7000.00 |
FAQ
- What is Sio Gene Therapies annual cash flow from investing activities?
- What is the all time high annual CFI for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sio Gene Therapies?
- What is Sio Gene Therapies TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sio Gene Therapies?
What is Sio Gene Therapies annual cash flow from investing activities?
The current annual CFI of SIOX is $3.65 M
What is the all time high annual CFI for Sio Gene Therapies?
Sio Gene Therapies all-time high annual cash flow from investing activities is $12.39 M
What is Sio Gene Therapies quarterly cash flow from investing activities?
The current quarterly CFI of SIOX is $0.00
What is the all time high quarterly CFI for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly cash flow from investing activities is $12.63 M
What is Sio Gene Therapies TTM cash flow from investing activities?
The current TTM CFI of SIOX is -$459.00 K
What is the all time high TTM CFI for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM cash flow from investing activities is $16.66 M